Deprescribing considerations for central nervous system-active polypharmacy in patients with dementia
J Am Geriatr Soc
.
2024 Nov 26.
doi: 10.1111/jgs.19294.
Online ahead of print.
Authors
Anna Hung
1
2
3
,
Matthew E Growdon
4
5
Affiliations
1
Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina, USA.
2
Duke-Margolis Institute for Health Policy, Durham, North Carolina, USA.
3
Center of Innovation to Accelerate Discovery and Practice Transformation, Durham VA Health Care System, Durham, North Carolina, USA.
4
Division of Geriatrics, University of California San Francisco, San Francisco, California, USA.
5
San Francisco VA Medical Center, San Francisco, California, USA.
PMID:
39600114
DOI:
10.1111/jgs.19294
No abstract available
Publication types
Editorial
Grants and funding
K76AG088411/AG/NIA NIH HHS/United States
R03AG078804/AG/NIA NIH HHS/United States
R24AG064025/AG/NIA NIH HHS/United States
R33AG057806/AG/NIA NIH HHS/United States
IK2 HX003359/HX/HSRD VA/United States
CIN 13-410/Durham Center of Innovation to ADAPT